SCHEMBL19031900

SCHEMBL19031900

O=C(O)C(=Cc1cccnc1)c1cncnc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 2/20 0.53
CYP19A1 P11511 1/20 0.53
AKR1C1 Q04828 1/20 0.50
CYP1A1 P04798 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP1B1 Q16678 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
ALDH1A1 P00352 3/20 0.47
GAA P10253 2/20 0.47
APP P05067 1/20 0.47
HCAR3 P49019 1/20 0.47
HCAR2 Q8TDS4 1/20 0.47
MAPT P10636 5/20 0.46
KDM4E B2RXH2 2/20 0.46
MAPK1 P28482 2/20 0.46
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
JUN P05412 1/20 0.46
NFKB1 P19838 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19031899 1.00 CYP11B2 (0.53) CYP11B2CYP19A1AKR1C1CYP1A1CYP1A2
SCHEMBL19031901 0.91 ALDH1A1 (0.51) CYP11B2CYP19A1AKR1C1CYP1A1CYP1A2
SCHEMBL9835080 0.87 AKR1C1 (0.68) CYP11B2CYP19A1AKR1C1CYP1A1CYP1A2
SCHEMBL4965828 0.87 AKR1C1 (0.68) CYP11B2CYP19A1AKR1C1CYP1A1CYP1A2
SCHEMBL4965835 0.87 AKR1C1 (0.68) CYP11B2CYP19A1AKR1C1CYP1A1CYP1A2
SCHEMBL3373184 0.87 AKR1C1 (0.67) AKR1C1CYP1A1CYP1A2CYP1B1CYP3A4
SCHEMBL3373182 0.87 AKR1C1 (0.67) AKR1C1CYP1A1CYP1A2CYP1B1CYP3A4
SCHEMBL8646379 0.84 AKR1C1 (0.68) CYP11B2CYP19A1AKR1C1CYP1A1CYP1A2
SCHEMBL8646375 0.84 AKR1C1 (0.68) CYP11B2CYP19A1AKR1C1CYP1A1CYP1A2
SCHEMBL5420133 0.82 MAPT (0.58) CYP11B2CYP19A1AKR1C1CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3394067-A1 4-AMINO-2-(1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL)-6-OXO-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THE RESPECTIVE (1H-INDAZOL-3-YL) DERIVATIVES AS CGMP MODULATORS FOR TREATING CARDIOVASCULAR DISEASES Merck Sharp & Dohme Corp. (US) 2018-10-31 EP disclosed
WO-2017112617-A1 4-AMINO-2-(1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL)-6-OXO-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THE RESPECTIVE (1H-INDAZOL-3-YL) DERIVATIVES AS CGMP MODULATORS FOR TREATING CARDIOVASCULAR DISEASES MERCK SHARP & DOHME CORP. (US) 2017-06-29 WO disclosed